Fuan Pharmaceutical Group Co (300194) - Total Assets

Latest as of March 2026: CN¥5.63 Billion CNY ≈ $824.31 Million USD

Based on the latest financial reports, Fuan Pharmaceutical Group Co (300194) holds total assets worth CN¥5.63 Billion CNY (≈ $824.31 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Fuan Pharmaceutical Group Co - Total Assets Trend (2007–2025)

This chart illustrates how Fuan Pharmaceutical Group Co's total assets have evolved over time, based on quarterly financial data. Also see Fuan Pharmaceutical Group Co (300194) total market value for the company's overall valuation and market capitalisation.

Fuan Pharmaceutical Group Co - Asset Composition Analysis

Current Asset Composition (December 2025)

Fuan Pharmaceutical Group Co's total assets of CN¥5.63 Billion consist of 33.8% current assets and 66.2% non-current assets. Review Fuan Pharmaceutical Group Co balance sheet liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	15.4%
Accounts Receivable	CN¥151.23 Million	2.6%
Inventory	CN¥643.05 Million	11.2%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥574.87 Million	10.0%
Goodwill	CN¥132.16 Million	2.3%

Asset Composition Trend (2007–2025)

This chart illustrates how Fuan Pharmaceutical Group Co's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Fuan Pharmaceutical Group Co stock price today for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Fuan Pharmaceutical Group Co's current assets represent 33.8% of total assets in 2025, a decrease from 45.1% in 2007.
Cash Position: Cash and equivalents constituted 15.4% of total assets in 2025, up from 7.7% in 2007.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 8.0% in 2007.
Asset Diversification: The largest asset category is inventory at 11.2% of total assets.

Fuan Pharmaceutical Group Co Competitors by Total Assets

Key competitors of Fuan Pharmaceutical Group Co based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Yunnan Baiyao Group Co Ltd SHE:000538	China	CN¥53.34 Billion
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	China	CN¥5.17 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Harbin Gloria Pharmaceuticals SHE:002437	China	CN¥3.14 Billion
Jiuzhitang Co Ltd SHE:000989	China	CN¥5.73 Billion
Renhe Pharmacy Co Ltd SHE:000650	China	CN¥7.93 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion

Fuan Pharmaceutical Group Co - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.25	2.01	1.72
Quick Ratio	1.44	1.27	1.12
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥1.01 Billion	CN¥1.09 Billion	CN¥745.08 Million

Fuan Pharmaceutical Group Co - Advanced Valuation Insights

This section examines the relationship between Fuan Pharmaceutical Group Co's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.03
Latest Market Cap to Assets Ratio	0.11
Asset Growth Rate (YoY)	-3.6%
Total Assets	CN¥5.76 Billion
Market Capitalization	$658.07 Million USD

Valuation Analysis

Below Book Valuation: The market values Fuan Pharmaceutical Group Co's assets below their book value (0.11x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Fuan Pharmaceutical Group Co's assets decreased by 3.6% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Fuan Pharmaceutical Group Co (2007–2025)

The table below shows the annual total assets of Fuan Pharmaceutical Group Co from 2007 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥5.76 Billion ≈ $843.37 Million	-3.60%
2024-12-31	CN¥5.98 Billion ≈ $874.85 Million	+0.04%
2023-12-31	CN¥5.98 Billion ≈ $874.47 Million	+1.67%
2022-12-31	CN¥5.88 Billion ≈ $860.13 Million	+3.01%
2021-12-31	CN¥5.71 Billion ≈ $835.03 Million	-4.46%
2020-12-31	CN¥5.97 Billion ≈ $874.01 Million	+26.12%
2019-12-31	CN¥4.74 Billion ≈ $693.02 Million	+10.33%
2018-12-31	CN¥4.29 Billion ≈ $628.14 Million	-8.45%
2017-12-31	CN¥4.69 Billion ≈ $686.12 Million	+6.62%
2016-12-31	CN¥4.40 Billion ≈ $643.51 Million	+77.39%
2015-12-31	CN¥2.48 Billion ≈ $362.77 Million	+35.31%
2014-12-31	CN¥1.83 Billion ≈ $268.11 Million	-1.67%
2013-12-31	CN¥1.86 Billion ≈ $272.67 Million	+3.25%
2012-12-31	CN¥1.80 Billion ≈ $264.10 Million	-0.68%
2011-12-31	CN¥1.82 Billion ≈ $265.90 Million	+424.97%
2010-12-31	CN¥346.14 Million ≈ $50.65 Million	+26.50%
2009-12-31	CN¥273.62 Million ≈ $40.04 Million	+35.06%
2008-12-31	CN¥202.59 Million ≈ $29.64 Million	+150.45%
2007-12-31	CN¥80.89 Million ≈ $11.84 Million	--

About Fuan Pharmaceutical Group Co

SHE:300194 China Drug Manufacturers - Specialty & Generic

Market Cap

$658.07 Million

CN¥4.50 Billion CNY

Market Cap Rank

#10956 Global

#3039 in China

Share Price

CN¥3.78

Change (1 day)

-0.53%

52-Week Range

CN¥3.34 - CN¥4.76

All Time High

CN¥10.53